Apr. 21, 2023
The Competition and Markets Authority (CMA) has provisionally found that the proposed merger of Cochlear Limited (Cochlear) and Oticon Medical, the hearing implants division of Demant A/S (Demant), could “result in worse outcomes for patients and higher prices for the NHS”. Cochlear and Oticon Medical are the only two suppliers of ‘Passive’ bone conductive solution (BCS) products in the UK,